The potential growth difference for the antinuclear antibody test market between 2021 and 2026 is USD 447.71 million. To get the exact yearly growth variance and the Y-O-Y growth rate, Talk to our analyst.
Key Market Dynamics:
- Market Driver - The key factor driving the global antinuclear antibody test market growth is the increasing demand for ANA tests. The antibodies produced by the immune system bind to the body's own tissues. The screening test detects if such antibodies are present in the body. The demand for antinuclear antibodies tests is increasing to identify autoimmune disorders such as rheumatoid arthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome, and many more. According to the Foundation for Peripheral Neuropathy report, in 2019, Guillain-Barre Syndrome (GBS) affects about 3,000-6,000 people in the US every year. Hence, a rise in the target population base is expected to fuel the demand for early screening for effective treatment. Also, rising infections due to the Epstein-Barr virus, the Campylobacter jejuni bacteria, and others are expected to drive the growth of the market in focus during the forecast period.
- Market Challenges - The key challenge to the global antinuclear antibody test market growth is the stringent regulations for the approval of medical diagnostic. These regulations differ from country to country. For instance, In the US, the FDA's Center for Devices and Radiological Health (CDRH) regulates the development, testing, manufacturing, labeling, and marketing of medical diagnostic devices. ANA test kits are classified under Class II devices, with low-to-moderate risks. Hence, vendors must obtain premarket notification 510(k) before marketing such devices. In Europe, the European Medicines Agency (EMA) regulates all medical devices, including diagnostic devices, under the European Union (EU) legislation 2017/745, which came into force in May 2017. After the medical diagnostic device passes the conformity assessment, manufacturers obtain a CE mark certification for the device, which allows them to commercialize and market their products. Such a lengthy procedure may lead to delays in the commercial launch of products, which will hinder the growth of the global ANA test market.
To learn about additional key drivers, trends, and challenges- Read our FREE Sample Report right now!
The antinuclear antibody test market report is segmented by End-user (Hospitals and Clinical diagnostic laboratories) and Geography (North America, Europe, Asia, and the Rest of the World (ROW).
The antinuclear antibody test market share growth by the hospital's segment will be significant for revenue generation. The significant increase in the number of hospitals will drive the growth of the market segment further during the forecast period. This is because hospitals are specialized healthcare institutions that offer best-in-class diagnosis and treatment services to patients with acute and complex conditions, including autoimmune disease.
View our sample report for additional insights into the contribution of all the segments
Some Companies Mentioned
The antinuclear antibody test market is fragmented and the vendors are deploying growth strategies such as investment in R and D to compete in the market.
-
- Abbott Laboratories
- Abcam Plc
- Antibodies Inc.
- Bio Rad Laboratories Inc.
- BioVision Inc.
- Grifols SA
- Immuno Concepts Ltd.
- Merck KGaA
- Orgentec Diagnostika GmbH
- PerkinElmer Inc.
- Quidel Corp.
- Seramun Diagnostica GmbH
- Thermo Fisher Scientific Inc.
- Transasia Bio Medicals Ltd.
- Trinity Biotech Plc
- Werfenlife SA
- ZEUS Scientific Inc.
- To gain access to more vendor profiles with their key offerings available with Technavio, Click Here
Related Reports:
- The advanced drug delivery systems market share is expected to increase by USD 91.79 billion from 2021 to 2026, at a CAGR of 7.41%. Download a free sample now!
- The carrier screening market share is expected to increase by USD 2.36 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 17.66%. Download a free sample now!
Antinuclear Antibody Test Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.93% |
Market growth 2022-2026 |
USD 447.71 million |
Market structure |
Fragmented |
YoY growth (%) |
7.24 |
Performing market contribution |
North America at 38% |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Abbott Laboratories, Abcam Plc, Antibodies Inc., Bio Rad Laboratories Inc., BioVision Inc., Grifols SA, Immuno Concepts Ltd., Merck KGaA, Orgentec Diagnostika GmbH, PerkinElmer Inc., Quidel Corp., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., Trinity Biotech Plc, Werfenlife SA, and ZEUS Scientific Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Key Topics Covered:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by End-user
- 5.1 Market segments
- Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
- Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
- 5.2 Comparison by End-user
- Exhibit 26: Chart on Comparison by End-user
- Exhibit 27: Data Table on Comparison by End-user
- 5.3 Hospitals - Market size and forecast 2021-2026
- Exhibit 28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)
- 5.4 Clinical diagnostic laboratories - Market size and forecast 2021-2026
- Exhibit 32: Chart on Clinical diagnostic laboratories - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Clinical diagnostic laboratories - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Clinical diagnostic laboratories - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by End-user
- Exhibit 36: Market opportunity by End-user ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 France - Market size and forecast 2021-2026
- Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11 Japan - Market size and forecast 2021-2026
- Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 85: Abbott Laboratories - Overview
- Exhibit 86: Abbott Laboratories - Business segments
- Exhibit 87: Abbott Laboratories - Key news
- Exhibit 88: Abbott Laboratories - Key offerings
- Exhibit 89: Abbott Laboratories - Segment focus
- 10.4 Antibodies Inc.
- Exhibit 90: Antibodies Inc. - Overview
- Exhibit 91: Antibodies Inc. - Product / Service
- Exhibit 92: Antibodies Inc. - Key offerings
- 10.5 BioVision Inc.
- Exhibit 93: BioVision Inc. - Overview
- Exhibit 94: BioVision Inc. - Product / Service
- Exhibit 95: BioVision Inc. - Key offerings
- 10.6 Grifols SA
- Exhibit 96: Grifols SA - Overview
- Exhibit 97: Grifols SA - Business segments
- Exhibit 98: Grifols SA - Key offerings
- Exhibit 99: Grifols SA - Segment focus
- 10.7 Immuno Concepts Ltd.
- Exhibit 100: Immuno Concepts Ltd. - Overview
- Exhibit 101: Immuno Concepts Ltd. - Product / Service
- Exhibit 102: Immuno Concepts Ltd. - Key offerings
- 10.8 Orgentec Diagnostika GmbH
- Exhibit 103: Orgentec Diagnostika GmbH - Overview
- Exhibit 104: Orgentec Diagnostika GmbH - Product / Service
- Exhibit 105: Orgentec Diagnostika GmbH - Key offerings
- 10.9 PerkinElmer Inc.
- Exhibit 106: PerkinElmer Inc. - Overview
- Exhibit 107: PerkinElmer Inc. - Business segments
- Exhibit 108: PerkinElmer Inc. - Key news
- Exhibit 109: PerkinElmer Inc. - Key offerings
- Exhibit 110: PerkinElmer Inc. - Segment focus
- 10.10 Quidel Corp.
- Exhibit 111: Quidel Corp. - Overview
- Exhibit 112: Quidel Corp. - Product / Service
- Exhibit 113: Quidel Corp. - Key offerings
- 10.11 Werfenlife SA
- Exhibit 114: Werfenlife SA - Overview
- Exhibit 115: Werfenlife SA - Product / Service
- Exhibit 116: Werfenlife SA - Key offerings
- 10.12 ZEUS Scientific Inc.
- Exhibit 117: ZEUS Scientific Inc. - Overview
- Exhibit 118: ZEUS Scientific Inc. - Product / Service
- Exhibit 119: ZEUS Scientific Inc. - Key offerings
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 120: Inclusions checklist
- Exhibit 121: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 122: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 123: Research methodology
- Exhibit 124: Validation techniques employed for market sizing
- Exhibit 125: Information sources
- 11.5 List of abbreviations
- Exhibit 126: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article